The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Arena Pharmaceuticals Inc

Nasdaq: ARNA
Last

(U.S.) $1.63

Today's change0.00 0.00%
Updated August 26 4:00 PM EDT. Delayed by at least 15 minutes.
 

Arena Pharmaceuticals Inc

Nasdaq: ARNA
Last

(U.S.) $1.63

Today's change0.00 0.00%
Updated August 26 4:00 PM EDT. Delayed by at least 15 minutes.

Arena Pharmaceuticals Inc closed at (U.S.)$1.63.

Over the last five days, shares have gained 0.62%, but are down 14.21% for the last year to date. Shares have underperformed the S&P 500 by 51.85% during the last year.

Key company metrics

  • Open(U.S.) $1.63
  • Previous close(U.S.) $1.63
  • High(U.S.) $1.66
  • Low(U.S.) $1.60
  • Bid / Ask(U.S.) $1.60 / (U.S.) $1.71
  • YTD % change-14.21%
  • Volume699,033
  • Average volume (10-day)929,061
  • Average volume (1-month)1,170,182
  • Average volume (3-month)1,577,913
  • 52-week range(U.S.) $1.30 to (U.S.) $2.99
  • Beta-0.80
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.44
Updated August 26 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue101089
Total other revenue--------
Total revenue101089
Gross profit7656
Total cost of revenue3433
Total operating expense36293734
Selling / general / administrative97109
Research & development19192022
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)5--4--
Other operating expenses, total--------
Operating income-26-19-29-25
Interest income (expense), net non-operating-2-2-2-2
Gain (loss) on sale of assets--------
Other--------
Income before tax-27-22-30-26
Income after tax-27-22-30-26
Income tax, total--------
Net income-27-22-30-26
Total adjustments to net income--------
Net income before extra. items-27-22-30-26
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-27-22-30-26
Inc. avail. to common incl. extra. items-27-22-30-26
Diluted net income-27-22-30-26
Dilution adjustment00--0
Diluted weighted average shares243243243242
Diluted EPS excluding extraordinary itemsvalue per share-0.11-0.09-0.13-0.11
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.09-0.09-0.11-0.11